Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Lessons from MATRICS.

Marder SR.

Schizophr Bull. 2011 Mar;37(2):233-4. doi: 10.1093/schbul/sbq166. Epub 2011 Feb 16. No abstract available.

2.

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, Essock S, Fenton WS, Frese FJ 3rd, Gold JM, Goldberg T, Heaton RK, Keefe RS, Kraemer H, Mesholam-Gately R, Seidman LJ, Stover E, Weinberger DR, Young AS, Zalcman S, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):203-13. doi: 10.1176/appi.ajp.2007.07010042. Epub 2008 Jan 2.

PMID:
18172019
3.

Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.

Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Seidman LJ, Stover E, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):221-8. doi: 10.1176/appi.ajp.2007.07010089. Epub 2008 Jan 2.

PMID:
18172017
4.

The treatment of negative symptoms: pharmacological and methodological issues.

Carpenter WT Jr.

Br J Psychiatry Suppl. 1996 May;(29):17-22. Review. No abstract available.

PMID:
8733819
5.

Clozapine, cognition, and schizophrenia.

Launer M.

Br J Psychiatry. 1993 Apr;162:567-8. No abstract available.

PMID:
8481757
6.

Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.

Keefe RS, Fox KH, Harvey PD, Cucchiaro J, Siu C, Loebel A.

Schizophr Res. 2011 Feb;125(2-3):161-8. doi: 10.1016/j.schres.2010.09.015. Epub 2010 Dec 31.

PMID:
21075600
7.

Medicine. What are the right targets for psychopharmacology?

Hyman SE, Fenton WS.

Science. 2003 Jan 17;299(5605):350-1. No abstract available.

PMID:
12532001
8.

[New drug therapies].

Olié JP, Baylé FJ.

Encephale. 1996 Oct;22 Spec No 3:63-71; discussion 76. Review. French. No abstract available.

PMID:
8954280
9.

Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia.

Sacco KA, Creeden C, Reutenauer EL, Vessicchio JC, Weinberger AH, George TP.

Schizophr Res. 2009 Feb;107(2-3):332-3. doi: 10.1016/j.schres.2008.09.026. Epub 2008 Nov 7. No abstract available.

PMID:
18995989
11.

The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.

Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR.

Am J Psychiatry. 2008 Feb;165(2):214-20. doi: 10.1176/appi.ajp.2007.07010043. Epub 2008 Jan 2.

PMID:
18172018
12.

Psychotropic effects of ritanserin, a selective S2 antagonist: an open study.

Strauss WH, Klieser E.

Eur Neuropsychopharmacol. 1991 May;1(2):101-5.

PMID:
1821698
13.

Atypical antipsychotic drugs improve cognition in schizophrenia.

Meltzer HY, Sumiyoshi T.

Biol Psychiatry. 2003 Feb 1;53(3):265-7; author reply 267-8. No abstract available.

PMID:
12559661
14.

Psychopharmacologic treatment of negative schizophrenic symptoms.

Opler LA, Albert D, Ramirez PM.

Compr Psychiatry. 1994 Jan-Feb;35(1):16-28. Review.

PMID:
7908618
15.

Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia.

Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK.

J Nerv Ment Dis. 2006 Apr;194(4):255-60.

PMID:
16614546
17.
18.

Thinking patterns and patterning drugs.

Seeman MV.

Can J Psychiatry. 1997 Apr;42(3):247-8. No abstract available.

PMID:
9114939
19.

Cognitive neuroscience and schizophrenia: translational research in need of a translator.

Cohen JD, Insel TR.

Biol Psychiatry. 2008 Jul 1;64(1):2-3. doi: 10.1016/j.biopsych.2008.04.031. No abstract available.

PMID:
18549873
20.

Neuropsychological profile in early-onset schizophrenia-spectrum disorders: measured with the MATRICS battery.

Holmén A, Juuhl-Langseth M, Thormodsen R, Melle I, Rund BR.

Schizophr Bull. 2010 Jul;36(4):852-9. doi: 10.1093/schbul/sbn174. Epub 2009 Feb 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk